The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Chronic Kidney Disease Suggest Revisions to the CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Instructions on How to Edit the Guidelines:
 * Log in
 * Click on "Edit"
 * Type in changes to guidelines
 * Click "Save page" at the bottom of the page

Class I Guidelines

 * 1) Creatinine clearance should be estimated in UA / NSTEMI patients and the doses of renally cleared drugs should be adjusted appropriately. (Level of Evidence: B)


 * 1) In chronic kidney disease patients undergoing angiography, isosmolar contrast agents are indicated, and are preferred. (Level of Evidence: A)